Top compounds associated with response to GALNTL5


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA Doxorubicin gCSI pan-cancer AAC -0.17 0.0003
mRNA AZ628 GDSC1000 pan-cancer AAC 0.17 0.0004
mRNA SB590885 GDSC1000 pan-cancer AAC 0.11 0.0004
mRNA PF-184 CTRPv2 pan-cancer AAC 0.11 0.0005
mRNA FQI-2 CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA phenformin GDSC1000 pan-cancer AAC 0.1 0.0009
mRNA CD-1530 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA VX-11e GDSC1000 pan-cancer AAC 0.11 0.001
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.002
Download CSV